Global Clinical Trial Imaging Services Market

Report ID : 1023 | Published : 2022-08-18 | Pages: 140 | Format: PDF/EXCEL

According to the latest research by InsightAce Analytic, the global Clinical Trial Imaging Services market is valued at US$ 1.37 billion in 2021, and it is expected to grow with a CAGR of 6.39% during a forecast period of 2022-2030. Clinical Trial is a protocol that studies new treatments and tests and checks their effects on human health. Clinical trials are used to treat cardiovascular diseases, cancer therapies, and many other health conditions. It is also an important part of the drug development process.  The imaging technique is a key factor in clinical trials. The clinical trial imaging technique offers data accuracy, adaptability, consistency, and compliance to clinical studies. The global clinical trial imaging services market has been rising due to the advanced medical technologies, development, and new software launch.The factors such as increasing use of clinical trial imaging devices, adoption of advanced medical technologies, rising government investments for research and development of imaging services are expected to boost the market's growth over the forecast period. Furthermore, increased healthcare expenditure and the rising prevalence of human health diseases are fueling the growth of the clinical trial imaging services market. The high cost of clinical imaging service with advanced technologies and poor reimbursement policies can downscale the market growth during the Forecast period 2022-2030.

 

The Global clinical trial imaging services market is segmented into Service Types, Therapeutic areas, End-users, and regions. The Service Types segment is further bifurcated into Clinical Trial Design & Consultation Services, Reading &, Operational Imaging Services, Project & Data Management Services, and Other Service Types. Operational Imaging Services and Project & Data Management Services and  are the main drivers of this market. In terms of Therapeutic areas, the market can be divided into Oncology, Neurology, Endocrinology, Analytical Services Cardiology, Gastroenterology, and Other Therapeutic Area. Oncology is the fastest-growing clinical trial imaging market segment due to the increasing prevalence of cancer, leading to growth in novel clinical trial imaging techniques.

Furthermore, the neurology segment is anticipated to boost the market, owing to the rise in the use of imaging in neurology clinical trials. By End-users, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, and Academic & Government Research Institutes. Pharmaceutical & Biotechnology Companies hold the largest share of this market. Based on the region, the clinical trial imaging services market is divided into North Pharmaceutical & Biotechnology Companies America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominated the global clinical trial imaging services market and will continue this trend over the forecast period, owing to ising adoption of advanced medical technologies, the increasing number of pharmaceutical companies, rand high clinical R&D investments by the government.

Some of the key Players of global clinical trial imaging services market are Biospective Inc.,  Calyx, Bioclinica Inc.,  Ert Clinical, Proscan Imaging, Ixico Plc, Intrinsic Imaging, Llc, Imaging Endpoints, Micron, Inc., Icon Plc., Medpace, Inc., Median Technologies, Pharmtrace,  and other Prominent Player.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trial Imaging Services Market Snapshot

Chapter 4. Global Clinical Trial Imaging Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Service Types, Estimates & Trend Analysis

5.1. By Service Types, & Market Share, 2019 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Service Types:

5.2.1. Clinical Trial Design & Consultation Services

5.2.2. Reading & Analytical Services

5.2.3. Operational Imaging Services

5.2.4. Project & Data Management Services

5.2.5. Other Service Types

Chapter 6. Market Segmentation 1: By Therapeutic Area Estimates & Trend Analysis

6.1. By Therapeutic Area & Market Share, 2019 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Therapeutic Area:

6.2.1. Oncology

6.2.2. Neurology

6.2.3. Endocrinology

6.2.4. Cardiology

6.2.5. Gastroenterology

6.2.6. Other Therapeutic Area

Chapter 7. Market Segmentation 1: By End-Users Estimates & Trend Analysis

7.1. By End-Users & Market Share, 2019 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-Users:

7.2.1. Pharmaceutical & Biotechnology Companies

7.2.2. Medical Device Manufacturers

7.2.3. Academic & Government Research Institutes

Chapter 8. Clinical Trial Imaging Services Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By Service Types, 2019 - 2030

8.1.2. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2019 - 2030

8.1.3. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By End-Users, 2019 - 2030

8.1.4. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts by country, 2019 - 2030

8.2. Europe

8.2.1. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, 2019 - 2030

8.2.2. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, 2019 - 2030

8.2.3. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, 2019 - 2030

8.2.4. Europe Clinical Trial Imaging Services Market revenue (US$ Million) by country, 2019 - 2030

8.3. Asia Pacific

8.3.1. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, 2019 - 2030

8.3.2. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, 2019 - 2030

8.3.3. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, 2019 - 2030

8.3.4. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) by country, 2019 - 2030

8.4. Latin America

8.4.1. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, (US$ Million)

8.4.2. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million)

8.4.3. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, (US$ Million)

8.4.4. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, (US$ Million)

8.5.2. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million)

8.5.3. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, (US$ Million)

8.5.4. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Bioclinica Inc.

9.2.2. Biospective Inc.

9.2.3. Calyx

9.2.4. Ert Clinical

9.2.5. Icon Plc.

9.2.6. Ixico Plc

9.2.7. Intrinsic Imaging, Llc

9.2.8. Imaging Endpoints

9.2.9. Micron, Inc.

9.2.10. Median Technologies

9.2.11. Medpace, Inc.

9.2.12. Pharmtrace

9.2.13. Proscan Imaging

9.2.14. Other Prominent Player

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Service Types

  • Clinical Trial Design & Consultation Services
  • Reading & Analytical Services
  • Operational Imaging Services
  • Project & Data Management Services
  • Other Service Types

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Therapeutic Area

  • Oncology
  • Neurology
  • Endocrinology
  • Cardiology
  • Gastroenterology
  • Other Therapeutic Area

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on End-Users

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic & Government Research Institutes

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030

  • S.
  • Canada

Europe clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

  

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trial Services Market Snapshot

Chapter 4. Global Clinical Trial Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. COVDI 19 Impact Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Major Investment, Partnerships and Collaborations in Cancer Research

Chapter 5. Market Segmentation 1: Phase Estimates & Trend Analysis

5.1. Phase Type & Market Share, 2019 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following Phase Type:

5.2.1. Phase I

5.2.2. Phase II

5.2.3. Phase III

Chapter 6. Market Segmentation 2: Therapy Area Estimates & Trend Analysis

6.1. Therapy Area & Market Share, 2019 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following Therapy Area:

6.2.1. Oncology

6.2.2. Neurological disorder

6.2.3. Metabolic disease

6.2.4. Cardiovascular

6.2.5. Rare diseases

6.2.6. Infectious diseases

6.2.7. Others

 Chapter 7. Clinical Trial Services Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Clinical Trial Services Market revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2030

7.1.2. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Therapy Area, 2019-2030

7.1.3. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2030

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Clinical Trial Services Market Revenue (US$ Million) by Phase, 2019-2030

7.2.2. Europe Clinical Trial Services Market Revenue (US$ Million) by Therapy Area, 2019-2030

7.2.3. Europe Clinical Trial Services Market Revenue (US$ Million) by Country, 2019-2030

7.2.3.1. Germany

7.2.3.2. France

7.2.3.3. Italy

7.2.3.4. Spain

7.2.3.5. UK

7.2.3.6. Romania

7.2.3.7. Netherland

7.2.3.8. Belgium

7.2.3.9. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) by phase, 2019-2030

7.3.2. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) by therapy area, 2019-2030

7.3.3. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) by country, 2019-2030

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Clinical Trial Services Market revenue (US$ Million) by phase, (US$ Million)

7.4.2. Latin America Clinical Trial Services Market revenue (US$ Million) by country, (US$ Million) 2019-2030

7.4.2.1. Brazil

7.4.2.2. Rest of Latin America

7.5. Middle East & Africa

7.5.1. Middle East & Africa Clinical Trial Services Market revenue (US$ Million) by phase, (US$ Million)

7.5.2. Middle East & Africa Clinical Trial Services Market revenue (US$ Million) by country, (US$ Million) 2019-2030

7.5.2.1. GCC Countries

7.5.2.2. Rest of Middle East & Africa

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Covance, Inc

8.2.2. Charles River Laboratories

8.2.3. Alcura Health

8.2.4. Parexel International

8.2.5. Accovion GmbH

8.2.6. ICON PLC

8.2.7. Chiltern International Limited

8.2.8. inVentiv International Pharma Services

8.2.9. Pharmaceutical Product Development LLC

8.2.10. Pharmnet

8.2.11. IQVIA

8.2.12. Syneos Health

8.2.13. Quotient Bioresearch

8.2.14. WuXi PharmaTech

8.2.15. Other Prominent Player

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Clinical Trial Imaging Services Market?

Our Clients

Media Citations

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$7786
$10000
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals

Review Request

We’ll review your request & send a personalized quote for cost and time needed

Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..